Stock Update (NYSE:BMY): Roche open to alliances in hunt for cancer drug combinations

[Reuters – UK Focus] – Roche, the world’s largest cancer drugmaker, is ready to collaborate with rivals to find new combination therapies for multi-pronged treatments, its chief executive said. Severin Schwan said the . . . → Read More: Stock Update (NYSE:BMY): Roche open to alliances in hunt for cancer drug combinations Similar Articles: Market Update (NYSE:BMY): Europe pushes back verdict on Bristol immune system cancer drug Stock Update (NYSE:BMY): Bristol-Myers Squibb Signs Exclusive Agreement with Bavarian Nordic for PROSTVAC®, a Prostate-Specific Antigen-Targeting Cancer Immunotherapy Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen ovarian cancer drug fails to improve overall survival